 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 4 | 1/1 | 返回列表 |
| 查看: 652 | 回復(fù): 3 | ||
| 本帖產(chǎn)生 1 個(gè) 翻譯EPI ，點(diǎn)擊這里進(jìn)行查看 | ||
霜葉金蟲 (小有名氣)
|
[求助]
翻譯一段摘要，謝謝
|
|
|
OBJECTIVES: Some large population-based studies have reported a dose-related increased risk of cataracts and glaucoma associated with use of inhaled corticosteroids (ICS) in patients with asthma or chronic obstructive pulmonary disease (COPD). We evaluated the association between use of ICS-containing products, specifically fluticasone propionate/salmeterol fixed-dose combination (FSC), and incidence of cataracts and glaucoma among patients with COPD in a large electronic medical record database in the United Kingdom. METHODS: We identified a cohort of patients aged 45 years and over with COPD in the General Practice Research Database (GPRD) between 2003 and 2006. Cases of incident cataracts or glaucoma were defined based on diagnosis and procedure codes and matched to controls from the risk set to estimate odds ratios (OR) and 95% confidence intervals (CI). The association with FSC or ICS exposure was modeled using conditional logistic regression. Medication exposure was assessed with respect to recency, duration, and number of prescriptions prior to the index date. Average daily dose was defined as none, low (1-250 mcg), medium (251-500 mcg), high (501-1000 mcg), or very high (1001+ mcg) using fluticasone propionate (FP) equivalents. RESULTS: We identified 2941 incident cataract cases and 327 incident glaucoma cases in the COPD cohort (n = 53,191). FSC or ICS prescriptions were not associated with risk of incident cataracts or glaucoma for any exposure category, after adjusting for confounders. We observed a lack of a dose response in all analyses, where low dose was the reference group. The odds of cataracts associated with FSC dose were medium OR: 1.1 (95% CI: 0.9-1.4); high OR: 1.2 (95% CI: 0.9-1.5); and very high OR: 1.2 (95% CI: 0.9-1.7). The odds of glaucoma associated with FSC dose: medium OR: 1.0 (95% CI: 0.5-2.1); high OR: 1.0 (95% CI: 0.5-2.0); and very high OR: 1.0 (95% CI: 0.4-2.8). CONCLUSIONS: FSC or other ICS exposure was not associated with an increased odds of cataracts or glaucoma, nor was a dose-response relationship observed in this population-based nested case-control study of COPD patients in the United Kingdom. |
回復(fù)此樓» 猜你喜歡
0856，材料與化工321分求調(diào)劑
已經(jīng)有6人回復(fù)
-
0703化學(xué)求調(diào)劑，各位老師看看我�。�！
已經(jīng)有5人回復(fù)
-
266分，求材料冶金能源化工等調(diào)劑
已經(jīng)有7人回復(fù)
-
張芳銘-中國農(nóng)業(yè)大學(xué)-環(huán)境工程專碩-298
已經(jīng)有3人回復(fù)
-
070300化學(xué)求調(diào)劑
已經(jīng)有4人回復(fù)
-
086000調(diào)劑
已經(jīng)有3人回復(fù)
-
320分，材料與化工專業(yè)，求調(diào)劑
已經(jīng)有4人回復(fù)
-
265求調(diào)劑
已經(jīng)有7人回復(fù)
-
295材料工程專碩求調(diào)劑
已經(jīng)有4人回復(fù)
-
高溫高壓反應(yīng)求助
已經(jīng)有4人回復(fù)
houbingxiao
木蟲 (小有名氣)
- 翻譯EPI: 1
- 應(yīng)助: 2 (幼兒園)
- 金幣: 1672.5
- 帖子: 99
- 在線: 31.4小時(shí)
- 蟲號: 2326487
- 注冊: 2013-03-07
- 性別: MM
- 專業(yè): 蛋白質(zhì)組學(xué)
樓主你可以考慮多給點(diǎn)金子來吸引有才之士~~~~ 
2樓2013-03-26 15:43:16
|
本帖內(nèi)容被屏蔽 |
3樓2013-03-26 15:51:34
Rio2016
木蟲 (小有名氣)
- 翻譯EPI: 72
- 應(yīng)助: 28 (小學(xué)生)
- 貴賓: 0.013
- 金幣: 3301.7
- 散金: 25
- 紅花: 6
- 帖子: 300
- 在線: 243.3小時(shí)
- 蟲號: 1910117
- 注冊: 2012-07-25
- 專業(yè): 抗腫瘤藥物藥理
【答案】應(yīng)助回帖
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
霜葉: 金幣+15, 翻譯EPI+1, ★★★★★最佳答案, 非常感謝，剩余的麻煩幫我再翻譯，謝謝啦 我已追加金幣 2013-03-26 18:15:44
霜葉(phu_grassman代發(fā)): 金幣+10 2013-04-14 09:52:13
霜葉: 金幣+15, 翻譯EPI+1, ★★★★★最佳答案, 非常感謝，剩余的麻煩幫我再翻譯，謝謝啦 我已追加金幣 2013-03-26 18:15:44
霜葉(phu_grassman代發(fā)): 金幣+10 2013-04-14 09:52:13
|
OBJECTIVES: 目標(biāo)： Some large population-based studies have reported a dose-related increased risk of cataracts and glaucoma associated with use of inhaled corticosteroids (ICS) in patients with asthma or chronic obstructive pulmonary disease (COPD). We evaluated the association between use of ICS-containing products, specifically fluticasone propionate/salmeterol fixed-dose combination (FSC), and incidence of cataracts and glaucoma among patients with COPD in a large electronic medical record database in the United Kingdom. 一些基于大量人群的研究報(bào)告稱，在患有哮喘或慢性阻塞性肺疾病(COPD)的病人發(fā)生白內(nèi)障和青光眼的風(fēng)險(xiǎn)，與他們使用吸入式糖皮質(zhì)激素(ICS)存在劑量遞增性。我們評估了使用含吸入式糖皮質(zhì)激素(ICS)產(chǎn)品，特別是丙酸氟替卡松/沙美特羅定量組合(FSC)，與大英帝國一個(gè)大型電子醫(yī)療記錄數(shù)據(jù)庫中慢性阻塞性肺病患者 白內(nèi)障和青光眼發(fā)生率的關(guān)系。 METHODS: 方法： We identified a cohort of patients aged 45 years and over with COPD in the General Practice Research Database (GPRD) between 2003 and 2006. Cases of incident cataracts or glaucoma were defined based on diagnosis and procedure codes and matched to controls from the risk set to estimate odds ratios (OR) and 95% confidence intervals (CI). 在研究數(shù)據(jù)庫(GPRD)中處于2003到2006年這段期間里，我們發(fā)現(xiàn)了一個(gè)年齡為45歲且患有COPD的同期組群。白內(nèi)障或青光眼的發(fā)生病例通過診斷和程序編碼來確定，并結(jié)合通過控制風(fēng)險(xiǎn)設(shè)定來計(jì)算比值比（OR）和置信區(qū)間為95%。 先這么多吧 、、確實(shí)不好翻譯  |
4樓2013-03-26 17:10:46
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 霜葉 的主題更新
| 4 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[有機(jī)交流]
高溫高壓反應(yīng)求助
 10+4
|
chibby 2026-03-25 | 4/200 |
|
|---|---|---|---|---|
|
[考研] 學(xué)碩274求調(diào)劑 +5 | Li李魚 2026-03-26 | 5/250 |
|
|
|
[考研] 083000學(xué)碩274求調(diào)劑 +4 | Li李魚 2026-03-26 | 4/200 |
|
|
|
[考研] 289求調(diào)劑 +7 | 新時(shí)代材料 2026-03-27 | 7/350 |
|
|
|
[考研] 0856調(diào)劑 +5 | 求求讓我有書讀?/a> 2026-03-26 | 6/300 |
|
|
|
[考研] 315調(diào)劑 +4 | 0860求調(diào)劑 2026-03-26 | 5/250 |
|
|
|
[考研] 0703化學(xué)338求調(diào)劑！ +6 | Zuhui0306 2026-03-26 | 7/350 |
|
|
|
[考研] 275求調(diào)劑 +10 | Micky11223 2026-03-25 | 12/600 |
|
|
|
[考研] 341求調(diào)劑 +7 | 青檸檬1 2026-03-26 | 7/350 |
|
|
|
[考研] 279求調(diào)劑 +6 | 紅衣隱官 2026-03-21 | 6/300 |
|
|
|
[考研] 297求調(diào)劑 +6 | 田洪有 2026-03-26 | 6/300 |
|
|
|
[考研] 281求調(diào)劑 +6 | Koxui 2026-03-24 | 7/350 |
|
|
|
[考研] 材料277求調(diào)劑 +5 | min3 2026-03-24 | 5/250 |
|
|
|
[考研] 291 求調(diào)劑 +7 | 化工2026屆畢業(yè)?/a> 2026-03-21 | 8/400 |
|
|
|
[考研] 打過很多競賽，085406控制工程300分，求調(diào)劑 +3 | askeladz 2026-03-26 | 3/150 |
|
|
|
[考研] 機(jī)械學(xué)碩總分317求調(diào)劑�。。�！ +4 | Acaciad 2026-03-25 | 4/200 |
|
|
|
[考研] B區(qū)考研調(diào)劑 +4 | yqdszhdap－ 2026-03-22 | 5/250 |
|
|
|
[考研] 材料專碩找調(diào)劑 +5 | 哈哈哈吼吼吼哈 2026-03-23 | 5/250 |
|
|
|
[考研]
 085404電子信息284分求調(diào)劑
+4
|
13659058978 2026-03-24 | 4/200 |
|
|
|
[考研] 0805材料320求調(diào)劑 +3 | 深海物語 2026-03-20 | 3/150 |
|